December 5, 2024 - 03:16

Alex Cooper, known for her popular podcast "Call Her Daddy," has announced an exciting new venture in the beverage industry. She is partnering with Nestlé to launch Unwell Hydration, an electrolyte drink specifically designed for women. This innovative beverage aims to address the hydration needs of women, providing essential electrolytes to help maintain optimal health and wellness.
Cooper's initiative comes at a time when there is a growing awareness of the importance of hydration, particularly among women who lead active lifestyles. Unwell Hydration promises to deliver a refreshing taste while also being beneficial for those looking to replenish their electrolytes after workouts or throughout their busy days.
The collaboration with Nestlé is expected to leverage the company's extensive experience in the beverage market, ensuring that Unwell Hydration meets high standards of quality and taste. As Cooper continues to expand her brand beyond podcasting, this new product could resonate well with her audience, promoting a healthier lifestyle for women everywhere.
July 19, 2026 - 06:51
Taylor Farms lettuce sample tests positive for Cyclospora as recall expandsA sample of shredded iceberg lettuce from Taylor Farms de Mexico has tested positive for the Cyclospora parasite, prompting the company to expand its recall across the United States. The...
July 18, 2026 - 17:51
Made in Tarrant: The Velvet Box owner starts a personal coaching business for womenA local business owner known for her work with The Velvet Box has expanded her professional focus, launching a new personal coaching service called The Conversation Architect. The program is...
July 18, 2026 - 02:52
‘Where does that leave our local business?’Edgartown`s Winter Street became a stage for two very different crowds Friday morning. On one side, a long line of mostly visitors snaked toward the entrance of a pop-up store run by Shopbop, the...
July 17, 2026 - 04:31
Stereotaxis completes major cardiology tech acquisitionStereotaxis has closed its acquisition of a major cardiology technology platform, a move that expands its footprint in the treatment of complex heart conditions. The deal, first announced in April,...